Want to join the conversation?
$XOM 2Q15 Q&A: Herrlin of Societe Generale asked if there are any issues for intermediate term projects coming off books long term. Jeff said, XOM will look to monetize them which many include some level of divestment. Specific to impairments, outlook to long term market fundamentals remain unchanged. Expect asset value fully cover carrying costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?